By the same token, one would expect HSCR patients with homozygous ETB−/− mutation to have impaired cardiovascular development and increased risks for hypertension and coronary artery disease due to the uncontrolled ET-1/ETA stimulation [20]. This evidence concerns the gene EDNRB and coronary artery disorder.